CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C00104 | BRD-A03946276 | BRD-A03946276 | -- | -- | -- | Details |
| C00105 | BRD-A03997826 | BRD-A03997826 | -- | -- | -- | Details |
| C00106 | BRD-A04020513 | BRD-A04020513 | -- | -- | l-buthionine-sulfoximine | Details |
| C00107 | BRD-A04026261 | YO-2 | -- | -- | -- | Details |
| C00108 | BRD-A04172077 | BRD-A04172077 | -- | -- | -- | Details |
| C00109 | BRD-A04231641 | BRD-A04231641 | -- | -- | -- | Details |
| C00110 | BRD-A04258855 | BRD-A04258855 | -- | -- | -- | Details |
| C00111 | BRD-A04260165 | SKF-83959 | -- | -- | -- | Details |
| C00112 | BRD-A04287157 | BRD-A04287157 | -- | -- | -- | Details |
| C00113 | BRD-A04308630 | genipin | -- | -- | -- | Details |
| C00114 | BRD-A04322457 | isoprenaline | ADRB1; ADRB2; ADRB3 | Adrenergic receptor agonist | -- | Details |
| C00115 | BRD-A04327189 | synephrine | ADRA1A | Adrenergic receptor agonist | -- | Details |
| C00116 | BRD-A04332542 | BRD-A04332542 | -- | -- | -- | Details |
| C00117 | BRD-A04352665 | maraviroc | CCR5 | CCK receptor antagonist | -- | Details |
| C00118 | BRD-A04392722 | BRD-A04392722 | -- | -- | -- | Details |
| C00119 | BRD-A04438777 | SKF-82958 | -- | -- | -- | Details |
| C00120 | BRD-A04510218 | BRD-A04510218 | -- | -- | -- | Details |
| C00121 | BRD-A04553218 | BRD-A04553218 | -- | -- | chlorphenamine | Details |
| C00122 | BRD-A04618830 | BRD-A04618830 | -- | -- | -- | Details |
| C00123 | BRD-A04661934 | 2-PMDQ | ADRA1A | Adrenergic receptor antagonist | -- | Details |
| C00124 | BRD-A04668240 | CGP-52432 | GABBR1 | GABA receptor antagonist | -- | Details |
| C00125 | BRD-A04691170 | BRD-A04691170 | -- | -- | -- | Details |
| C00126 | BRD-A04706586 | bucladesine | PRKACA | CAMP stimulant; Adenosine receptor agonist | -- | Details |
| C00127 | BRD-A04756508 | norgestimate | PGR | Progesterone receptor agonist | -- | Details |
| C00128 | BRD-A04831598 | 2-aminotetralin | -- | -- | 2-AMINOTETRALIN | Details |
| C00129 | BRD-A04845303 | BRD-A04845303 | -- | -- | -- | Details |
| C00130 | BRD-A04975445 | BRD-A04975445 | -- | -- | -- | Details |
| C00131 | BRD-A05077036 | 614_7033_4267 | -- | -- | -- | Details |
| C00132 | BRD-A05186015 | bupropion | SLC6A2; SLC6A3 | Dopamine uptake inhibitor | -- | Details |
| C00133 | BRD-A05217942 | BRD-A05217942 | -- | -- | -- | Details |
| C00134 | BRD-A05334458 | lisofylline | -- | -- | -- | Details |
| C00135 | BRD-A05352148 | ipratropium | CHRM1; CHRM2; CHRM3; CHRM4 | Acetylcholine receptor antagonist | -- | Details |
| C00136 | BRD-A05376797 | BRD-A05376797 | -- | -- | -- | Details |
| C00137 | BRD-A05422420 | BRD-A05422420 | -- | -- | -- | Details |
| C00138 | BRD-A05456882 | BRD-A05456882 | -- | -- | -- | Details |
| C00139 | BRD-A05457250 | BAY-K8644 | CACNA1C | Calcium channel activator; L-type calcium channel activator | -- | Details |
| C00140 | BRD-A05523972 | telmesteine | -- | -- | -- | Details |
| C00141 | BRD-A05565054 | BRD-A05565054 | -- | -- | -- | Details |
| C00142 | BRD-A05581237 | dinorcitalopram-oxalate | -- | -- | -- | Details |
| C00143 | BRD-A05635986 | BRD-A05635986 | -- | -- | -- | Details |
| C00144 | BRD-A05680309 | BRD-A05680309 | XIAP; CASP8 | XIAP inhibitor; Caspase activator | -- | Details |
| C00145 | BRD-A05715709 | BRD-A05715709 | -- | -- | -- | Details |
| C00146 | BRD-A05729358 | CPCCOEt | GRM1 | Glutamate receptor antagonist | -- | Details |
| C00147 | BRD-A05821830 | docetaxel | TUBB | Tubulin inhibitor | -- | Details |
| C00148 | BRD-A05823365 | BRD-A05823365 | -- | -- | -- | Details |
| C00149 | BRD-A05828965 | BRD-A05828965 | -- | -- | -- | Details |
| C00150 | BRD-A05831822 | BRD-A05831822 | -- | -- | -- | Details |
| C00151 | BRD-A05874290 | DL-TBOA | SLC1A1; SLC1A2; SLC1A3 | Excitatory amino acid transporter inhibitor | -- | Details |
| C00152 | BRD-A05883068 | BRD-A05883068 | -- | -- | -- | Details |
| C00153 | BRD-A05956997 | BRD-A05956997 | -- | -- | -- | Details |
| C00154 | BRD-A06131576 | BRD-A06131576 | -- | -- | -- | Details |
| C00155 | BRD-A06149038 | BRD-A06149038 | -- | -- | -- | Details |
| C00156 | BRD-A06158172 | BRD-A06158172 | -- | -- | -- | Details |
| C00157 | BRD-A06210771 | icariin | -- | -- | -- | Details |
| C00158 | BRD-A06232236 | BRD-A06232236 | -- | -- | -- | Details |
| C00159 | BRD-A06276885 | BRD-A06276885 | -- | -- | -- | Details |
| C00160 | BRD-A06304526 | alvespimycin | HSP90AA1 | HSP inhibitor | -- | Details |
| C00161 | BRD-A06327019 | BRD-A06327019 | -- | -- | -- | Details |
| C00162 | BRD-A06352418 | terfenadine | HRH1; KCNH2 | Histamine receptor antagonist | -- | Details |
| C00163 | BRD-A06352508 | SB-218078 | CHEK1 | CHK inhibitor | -- | Details |
| C00164 | BRD-A06390036 | hydroquinidine | -- | -- | -- | Details |
| C00165 | BRD-A06416737 | BRD-A06416737 | -- | -- | -- | Details |
| C00166 | BRD-A06426627 | diclazuril | -- | -- | -- | Details |
| C00167 | BRD-A06471483 | BRD-A06471483 | -- | -- | -- | Details |
| C00168 | BRD-A06578049 | BRD-A06578049 | -- | -- | -- | Details |
| C00169 | BRD-A06641369 | BRD-A06641369 | -- | -- | -- | Details |
| C00170 | BRD-A06664848 | BRD-A06664848 | -- | -- | -- | Details |
| C00171 | BRD-A06726973 | dibutyrylcyclic-gmp | -- | -- | -- | Details |
| C00172 | BRD-A06779035 | BRD-A06779035 | -- | -- | -- | Details |
| C00173 | BRD-A06784547 | MRS-1334 | ADORA3 | Adenosine receptor antagonist | -- | Details |
| C00174 | BRD-A06837695 | BRD-A06837695 | -- | -- | -- | Details |
| C00175 | BRD-A06840811 | BRD-A06840811 | -- | -- | -- | Details |
| C00176 | BRD-A06909528 | BRD-A06909528 | -- | -- | -- | Details |
| C00177 | BRD-A06916187 | CPI-613 | PDHA1 | Pyruvate dehydrogenase inhibitor | -- | Details |
| C00178 | BRD-A06929388 | CVF-SUMO-13 | -- | -- | -- | Details |
| C00179 | BRD-A06935312 | fusidic-acid | -- | -- | -- | Details |
| C00180 | BRD-A07000685 | hydrocortisone-hemisuccinate | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C00181 | BRD-A07029265 | ipratropium | CHRM3; CHRM4; CHRM1; CHRM2 | Acetylcholine receptor antagonist | -- | Details |
| C00182 | BRD-A07106394 | tryptophan | -- | -- | -- | Details |
| C00183 | BRD-A07195938 | BRD-A07195938 | -- | -- | -- | Details |
| C00184 | BRD-A07207424 | Ro-20-1724 | PDE4A; PDE4B; PDE4D | Phosphodiesterase inhibitor | -- | Details |
| C00185 | BRD-A07214340 | BRD-A07214340 | -- | -- | -- | Details |
| C00186 | BRD-A07232941 | 8-M-PDOT | MTNR1A; MTNR1B | Melatonin receptor agonist | -- | Details |
| C00187 | BRD-A07395371 | esmolol | ADRB1 | Adrenergic receptor antagonist | -- | Details |
| C00188 | BRD-A07407288 | BRD-A07407288 | -- | -- | -- | Details |
| C00189 | BRD-A07440155 | labetalol | ADRA1D; ADRA1A; ADRB1; ADRB2 | Adrenergic receptor antagonist | -- | Details |
| C00190 | BRD-A07563059 | bopindolol | ADRB1; ADRB2 | Adrenergic receptor antagonist | -- | Details |
| C00191 | BRD-A07614565 | BRD-A07614565 | -- | -- | -- | Details |
| C00192 | BRD-A07704283 | isofloxythepin | -- | -- | -- | Details |
| C00193 | BRD-A07765530 | BRD-A07765530 | -- | -- | epinephrine-(racemic) | Details |
| C00194 | BRD-A07780951 | orciprenaline | ADRB2 | Adrenergic receptor agonist | -- | Details |
| C00195 | BRD-A07815743 | kakonein | -- | -- | -- | Details |
| C00196 | BRD-A07824748 | flavanone | -- | -- | -- | Details |
| C00197 | BRD-A07861932 | BRD-A07861932 | -- | -- | -- | Details |
| C00198 | BRD-A07870296 | BRD-A07870296 | -- | -- | bicuculline-(+) | Details |
| C00199 | BRD-A07875874 | cilnidipine | CACNA1B | Calcium channel blocker | -- | Details |
| C00200 | BRD-A07893380 | vigabatrin | ABAT | GABA aminotransferase inhibitor | -- | Details |
| C00201 | BRD-A07932845 | metitepine | HTR5A; HTR6; HTR7 | Anti-HCVE2 | -- | Details |
| C00202 | BRD-A07944983 | BRD-A07944983 | -- | -- | -- | Details |
| C00203 | BRD-A07952294 | BRD-A07952294 | -- | -- | -- | Details |